Involvement of urokinase-type plasminogen activator in sphingosylphosphorylcholine-induced angiogenesis

Experimental Dermatology

Volumn 14, Issue 5, 2005, Pages 356-362

  Piao, Yong Jun ^a   Lee, Chang Hi ^a   Zhu, Ming Ji ^a,b   Kye, Kyung Chae ^a   Kim, Jin Man ^a   Seo, Young Joon ^a   Suhr, Ki Beom ^a   Park, Jang Kyu ^a   Kim, Chang Deok ^a   Lee, Jeung Hoon ^a  

^a Chungnam National University   (South Korea)

^b JILIN UNIVERSITY   (China)

Author keywords

Angiogenesis; Human umbilical vein endothelial cells; Sphingosylphosphorylcholine; Urokinase type plasminogen activator

Indexed keywords

PROUROKINASE; SPHINGOSYLPHOSPHORYLCHOLINE; WOUND HEALING PROMOTING AGENT;

ACCELERATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CELL CULTURE; CELL MIGRATION; CELL STIMULATION; CHEMOTAXIS; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; SPROUTING; UMBILICAL VEIN; VASCULAR RING; WOUND CLOSURE; WOUND HEALING;

ANIMALS; AORTA; CAPILLARIES; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLCHOLINE; RATS; RATS, INBRED F344; SPHINGOSINE; UMBILICAL VEINS; URINARY PLASMINOGEN ACTIVATOR; WOUND HEALING;

EID: 18844432295     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.00272.x     Document Type: Article

References (34)

1. Chan J C, Duszczyszyn D A, Castellino F J, Ploplis V A. > Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice. Am J Pathol 2001: 159: 1681-1688.
2. Suhr K B, Tsuboi R, Ogawa H. Sphingosylphosphorylcholine stimulates contraction of fibroblast-embedded collagen gel. Br J Dermatol 2000: 143: 66-71.
3. Dvorak H F, Nagy J A, Feng D, Brown L F, Dvorak A M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999: 237: 97-132.
4. Gerwins P, Skoldenberg E, Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol 2000: 34: 185-194.
5. Leahy K M, Koki A T, Masferrer J L. Role of cyclooxygenases in angiogenesis. Curr Med Chem 2000: 7: 1163-1170.
6. Yatomi Y, Ohmori T, Rile G et al. Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood 2000: 96: 3431-3438.
7. Spiegel S, Milstien S. Sphingolipid metabolites: members of a new class of lipid second messengers. J Membr Biol 1995: 146: 225-237.
8. Zanglis A, Lianos E A, Demopoulos C A. The biological activity of acetylated sphingosylphosphorylcholine derivatives. Int J Biochem Cell Biol 1996: 28: 63-74.
9. Sun L, Xu L, Henry F A, Spiegel S, Nielsen T B. A new wound healing agent-sphingosylphosphorylcholine. J Invest Dermatol 1996: 106: 232-237.
10. Wakita H, Matsushita K, Nishimura K, Tokura Y, Furukawa F, Takigawa M. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes. J Invest Dermatol 1998: 110: 253-258.
11. Boguslawski G, Lyons D, Harvey K A, Kovala A T, English D. Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis. Biochem Biophys Res Commun 2000: 272: 603-609.
12. Boguslawski G, Grogg J R, Welch Z et al. Migration of vascular smooth muscle cells induced by sphingosine 1-phosphate and related lipids: potential role in the angiogenic response. Exp Cell Res 2002: 274: 264-274.
13. Nicosia R F, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 1990: 63: 115-122.
14. Pepper M S, Vassalli J D, Montesano R, Orci L. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol 1987: 105: 2535-2541.
15. Lee Oh, Kim Y M, Lee Y M et al. Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun 1999: 264: 743-750.
16. Kye K C, Chae E K, Piao Y J et al. Signaling events during induction of plasminogen activator inhibitor-1 expression by sphingosylphosphorylcholine in cultured human dermal fibroblasts. J Invest Dermatol 2004: 122: 1365-1371.
17. Masson V, Devy L, Grignet-Debrus C et al. Mouse Aortic Ring Assay: a new approach of the molecular genetics of angiogenesis. Biol Proced Online 2002: 4: 24-31.
18. Morales D E, McGowan K A, Grant D S et al. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995: 91: 755-763.
19. Providence K M, White L A, Tang J, Gonclaves J, Staiano-Coico L, Higgins P J. Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene. J Cell Sci 2002: 115: 3767-3777.
20. Schnaper H W, Barnathan E S, Mazar A et al. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways. J Cell Physiol 1995: 165: 107-118.
21. Sandberg T, Casslen B, Gustavsson B, Benraad T J. Human endothelial cell migration is stimulated by urokinase plasminogen activator: plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis. Biol Reprod 1998: 59: 759-767.
22. McGrath M H, Emery J M. The effect of inhibition of angiogenesis in granulation tissue on wound healing and the fibroblast. Ann Plast Surg 1985: 15: 105-122.
23. Lee P C, Salyapongse A N, Bragdon G A et al. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 1999: 277: H1600-H1608.
24. Streit M, Velasco P, Riccardi L et al. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J 2000: 19: 3272-3282.
25. Echtermeyer F, Streit M, Wilcox-Adelman S et al. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 2001: 107: R9-R14.
26. Clair T, Aoki J, Koh E et al. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res 2003: 63: 5446-5453.
27. Paik J H, Chae SS, Lee M J, Thangada S, Hla T. Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J Biol Chem 2001: 276: 11830-11837.
28. Pepper M S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001: 21: 1104-1117.
29. Heymans S, Luttun A, Nuyens D et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999: 5: 1135-1142.
30. Brodsky S, Chen J, Lee A, Akassoglou K, Norman J, Goligorsky M S. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. Am J Physiol Heart Circ Physiol 2001: 281: H1784-H1792.
31. Devy L, Blacher S, Grignet-Debrus C et al. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J 2002: 16: 147-154.
32. Jensen P J, Baird J, Morioka S, Lessin S, Lazarus G S. Epidermal plasminogen activator is abnormal in cutaneous lesions. J Invest Dermatol 1988: 90: 777-782.
33. Morioka S, Lazarus G S, Baird J L, Jensen P J. Migrating keratinocytes express urokinase-type plasminogen activator. J Invest Dermatol 1987: 88: 418-423.
34. Pollanen J, Saksela O, Salonen E M et al. Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol 1987: 104: 1085-1096.